|
June 06.
|
|
Health
effects of smoking tobacco, smokeless tobacco, and nicotine:
Summary:
·
Cigarette smoking: There is
strong epidemiological and biochemical evidence that cigarette smoking
during pregnancy significantly increases the risk of low infant birth
weight, premature labour and perinatal mortality, also sudden infant death
syndrome.1
·
Smokeless tobacco:
Sweden:
birthweight is lowered by smoking, and to a
lesser extent by smokeless.1
India
Use of Indian smokeless tobacco in Indian women is associated
with increased risk of stillbirth and decreased birth weight.2 4
Africa
Use of African snuff in Black African women does not decrease birthweight significantly.3
- Nicotine: All organs except the brain complete their
development in the first 3 months of pregnancy, but the brain
continues to grow, and while growing is susceptible to nicotine.4
Conclusion:
- There
is no safe dose of nicotine in pregnancy. Nicotine replacement
therapy is justified if smoking cessation is otherwise unlikely.
Patches that are used for 16 rather than 24 hours are preferred.
- Smoking
greatly, and smokeless to a lesser extent, puts the fetus and infant
at risk.
- Smoking
in pregnancy reduces birthweight,
increases risk of preterm delivery, and perinatal
mortality. Smokeless tobacco has similar but generally less severe
effects. In Mumbai women, presumably often with marginal nutrition,
income, or health services, all cause mortality was increased. The
content of smokeless tobacco does not plausibly account for these
results, as the smokeless effects in pregnancy may be due to its nicotine.
- During
pregnancy smoking and smokeless tobacco should be avoided, and
nicotine only considered as a temporary stop smoking aid.
|
Compared with no use of tobacco or nicotine
|
Cigarette
smoking
|
Smokeless
tobacco as used
|
Nicotine only
|
Second hand smoke
(not from mother)
|
|
Western
countries
|
Accounts for 2.7% to 5.2% of the variance in
birthweight.1
|
Few women use smokeless. No data
|
|
|
|
India (Mumbai)2
|
Few women smoke.
|
Reduced by 105g. on
average.
|
No data
|
No data
|
|
South
Africa3
|
Reduced by 165 g
|
Reduced by 17g Not significant.
|
No data
|
Birthweight not affected.
|
|
Compared with no use of tobacco or nicotine
|
Cigarette
smoking
|
Smokeless
tobacco as used
|
Nicotine only
|
Second hand
smoke (not from mother)
|
|
Western
countries
|
Preterm delivery risk increased; OR 1.98.1
|
Preterm delivery risk increased OR 1.571
|
No data
|
|
|
India (Mumbai)
|
Few women smoke
|
Risk of pre-term birth before 37 weeks was increased
40%, and five fold before 32 weeks.3
|
|
|
|
South Africa
|
No data
|
Shorter gestational age.5
|
No data
|
|
|
Compared with no use of tobacco or nicotine
|
Cigarette
smoking
|
Smokeless
tobacco as used
|
Nicotine only
|
Second hand smoke
(not from mother)
|
|
Western
countries
|
Main risk factor for sudden infant death syndrome in
NZ.
|
No data
|
No data.
|
|
|
India (Mumbai)
|
Risk increased.
|
Stillbirth risk increased 2.6 times6
|
No data
|
|
|
South Africa
|
No data
|
No data
|
No data
|
|
|
|
1
England LJ, Levine RJ, Mills JL, Klebanoff
MA, Yu KF, Cnattingius S. Adverse pregnancy
outcomes in snuff users. Am J Obstet Gynecol 2003;189:939-43. (Sweden)
2
Secker-Walker RH, Vacek PM.
Relationships between cigarette smoking during pregnancy, gestational
age, maternal weight gain, and infant birthweight.
Addict Behav 2003; 28: 55-66. (USA)
3.
Gupta PC Sreevidya S. Smokeless tobacco
use, birth weight, and gestational age: population based prospective
cohort study of 1217 women in Mumbai, India. BMJ 2004; 328: 1538.
4 Oncken CA, Hardardottir, H,
Smeltzer JS. Human studies of nicotine
replacement during pregnancy. Ch. 11 in Ncotine
Safety and Toxicity ed. NL Benowitz. Oxford OUP 1998.
5. Steyn
K, de Wet T, Salloojee Y, Nel
H, Yach D. The influence of maternal cigarette
smoking, snuff use and passive smoking on pregnancy outcomes: the Birth
to Ten Study. Paediatric and Perinatal Epidemiology 2006; 20: 90-99. (South
Africa)
6. Gupta PC, Subramoney
S. Smokeless tobacco use and risk of stillbirth: a cohort study in Mumbai, India. Epidemiology 2006 Jan;17(1):47-51.
|
Dr Murray Laugesen QSO chair; Prof Ross McCormick, Sir John Scott KBE, Trish
Fraser MPH, Dr Marewa Glover, Trustees
|